KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Operating Expenses (2016 - 2025)

Incyte (INCY) has disclosed Operating Expenses for 16 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 33.49% year-over-year to $1.2 billion, compared with a TTM value of $3.6 billion through Dec 2025, down 13.24%, and an annual FY2025 reading of $3.6 billion, down 13.24% over the prior year.
  • Operating Expenses was $1.2 billion for Q4 2025 at Incyte, up from $922.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.5 billion in Q2 2024 and bottomed at $505.9 million in Q1 2021.
  • Average Operating Expenses over 5 years is $804.9 million, with a median of $772.4 million recorded in 2023.
  • The sharpest move saw Operating Expenses crashed 58.95% in 2021, then skyrocketed 100.03% in 2024.
  • Year by year, Operating Expenses stood at $752.1 million in 2021, then grew by 13.89% to $856.6 million in 2022, then fell by 3.56% to $826.1 million in 2023, then rose by 6.19% to $877.2 million in 2024, then soared by 33.49% to $1.2 billion in 2025.
  • Business Quant data shows Operating Expenses for INCY at $1.2 billion in Q4 2025, $922.5 million in Q3 2025, and $685.2 million in Q2 2025.